Karen D. Garay Buenrostro is a Clinical Research Associate specializing in biomedical and clinical sciences. She currently serves within US Site Management & Monitoring (CRA) operations at AstraZeneca, contributing to the coordination and oversight of clinical research activities. Parallel to her industry role, she maintains an academic affiliation with the School of Medicine and Health Sciences at Tecnológico de Monterrey (Mexico), where she has participated as a co-author in various scientific studies. Her research involvement spans molecular biology, gene regulation, cellular proliferation, and oncological processes, with particular attention to pathways influencing apoptosis and osteoblastic activity. Her publications include collaborative work exploring compounds such as resveratrol and peonidin-3-O-glucoside, as well as studies on the effects of vitamins A, D₂, and D₃ on cancer cell proliferation. In addition to her scientific contributions, Garay Buenrostro has been involved in academic outreach through Prepanet, serving as a Tutor Coordinator between 2019 and 2020 to support student engagement in remote education programs. Karen D. Garay Buenrostro’s professional path reflects a consistent alignment between clinical research excellence and academic collaboration, bridging pharmaceutical development and scientific inquiry within leading institutions.